109 related articles for article (PubMed ID: 34910336)
21. Analytical and Clinical Evaluation of the Semiquantitative Elecsys Anti-SARS-CoV-2 Spike Protein Receptor Binding Domain Antibody Assay on the Roche cobas e602 Analyzer.
Chan CW; Yi X; Lenza M; Baldwin AD; Jakalski J; Tesic V; Yeo KJ
Am J Clin Pathol; 2022 Jan; 157(1):109-118. PubMed ID: 34463315
[TBL] [Abstract][Full Text] [Related]
22. Fluorescence-Based Lateral Flow Immunoassay for Quantification of Infliximab: Analytical and Clinical Performance Evaluation.
Kim ES; Chon H; Kwon Y; Lee M; Kim MJ; Choe YH
Ther Drug Monit; 2024 May; ():. PubMed ID: 38287890
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Three Immunoassays for the Rapid Detection of SARS-CoV-2 antigens.
Baccani I; Morecchiato F; Chilleri C; Cervini C; Gori E; Matarrese D; Bassetti A; Bonizzoli M; Mencarini J; Antonelli A; Rossolini GM
Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115434. PubMed ID: 34174523
[TBL] [Abstract][Full Text] [Related]
24. Determination of SARS-CoV-2 antibodies with assays from Diasorin, Roche and IDvet.
Krüttgen A; Cornelissen CG; Dreher M; Hornef MW; Imöhl M; Kleines M
J Virol Methods; 2021 Jan; 287():113978. PubMed ID: 32979407
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the Clinical Performances of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elecsys Total SARS-CoV-2 Antibody Assays.
Harley K; Gunsolus IL
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33106364
[TBL] [Abstract][Full Text] [Related]
26. Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays.
Kweon OJ; Lim YK; Kim HR; Kim MC; Choi SH; Chung JW; Lee MK
PLoS One; 2020; 15(10):e0240395. PubMed ID: 33091042
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Two Chemiluminescent and Three ELISA Immunoassays for the Detection of SARS-CoV-2 IgG Antibodies: Implications for Disease Diagnosis and Patients' Management.
Speletas M; Kyritsi MA; Vontas A; Theodoridou A; Chrysanthidis T; Hatzianastasiou S; Petinaki E; Hadjichristodoulou C
Front Immunol; 2020; 11():609242. PubMed ID: 33424863
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience.
Infantino M; Grossi V; Lari B; Bambi R; Perri A; Manneschi M; Terenzi G; Liotti I; Ciotta G; Taddei C; Benucci M; Casprini P; Veneziani F; Fabbri S; Pompetti A; Manfredi M
J Med Virol; 2020 Sep; 92(9):1671-1675. PubMed ID: 32330291
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Two Automated Immunoassays for the Detection of SARS-CoV-2 Nucleocapsid Antibodies.
Hubbard JA; Geno KA; Khan J; Szczepiorkowski ZM; de Gijsel D; Ovalle AA; AlSalman AS; Gallagher TL; Johnston AA; Tibbetts AR; Vital SE; Cervinski MA; Nerenz RD
J Appl Lab Med; 2021 Mar; 6(2):429-440. PubMed ID: 32976593
[TBL] [Abstract][Full Text] [Related]
30. Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.
Chiereghin A; Zagari RM; Galli S; Moroni A; Gabrielli L; Venturoli S; Bon I; Rossini G; Saracino IM; Pavoni M; Lafratta S; Deni A; Felici S; Borghi M; Guerra L; Raumer L; Lodi V; Viale P; Attard L; Lazzarotto T;
Front Public Health; 2020; 8():620222. PubMed ID: 33681115
[No Abstract] [Full Text] [Related]
31. Serum Interleukin-6 Concentrations and the Severity of COVID-19 Pneumonia: A Retrospective Study at a Single Center in Bengbu City, Anhui Province, China, in January and February 2020.
Sun H; Guo P; Zhang L; Wang F
Med Sci Monit; 2020 Nov; 26():e926941. PubMed ID: 33175722
[TBL] [Abstract][Full Text] [Related]
32. Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response.
Mahmoud SA; Ganesan S; Naik S; Bissar S; Zamel IA; Warren KN; Zaher WA; Khan G
Microbiol Spectr; 2021 Oct; 9(2):e0073321. PubMed ID: 34585943
[TBL] [Abstract][Full Text] [Related]
33. Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19.
Flinck H; Rauhio A; Luukinen B; Lehtimäki T; Haapala AM; Seiskari T; Aittoniemi J
Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115197. PubMed ID: 32977117
[TBL] [Abstract][Full Text] [Related]
34. Analytical performances of a novel point-of-care procalcitonin assay.
Dupuy AM; Bargnoux AS; Andreeva A; Zins C; Kuster N; Badiou S; Cristol JP
Pract Lab Med; 2020 Jan; 18():e00145. PubMed ID: 31720356
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the Elecsys® Anti-SARS-CoV-2 immunoassay with the EDI™ enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma.
Egger M; Bundschuh C; Wiesinger K; Gabriel C; Clodi M; Mueller T; Dieplinger B
Clin Chim Acta; 2020 Oct; 509():18-21. PubMed ID: 32485155
[TBL] [Abstract][Full Text] [Related]
36. Remote Fingerstick Blood Collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Testing.
Garcia-Beltran WF; Miller TE; Kirkpatrick G; Nixon A; Astudillo MG; Yang D; Mahanta LM; Murali M; Dighe AS; Lennerz J; Thierauf J; Naranbhai V; Iafrate AJ
Arch Pathol Lab Med; 2021 Apr; 145(4):415-418. PubMed ID: 33264390
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic performance of the Elecsys SARS-CoV-2 antigen assay in the clinical routine of a tertiary care hospital: Preliminary results from a single-center evaluation.
Mueller T; Kompatscher J; La Guardia M
J Clin Lab Anal; 2021 Aug; 35(8):e23906. PubMed ID: 34251047
[TBL] [Abstract][Full Text] [Related]
38. A 10-Minute "Mix and Read" Antibody Assay for SARS-CoV-2.
Rusanen J; Kareinen L; Levanov L; Mero S; Pakkanen SH; Kantele A; Amanat F; Krammer F; Hedman K; Vapalahti O; Hepojoki J
Viruses; 2021 Jan; 13(2):. PubMed ID: 33498157
[TBL] [Abstract][Full Text] [Related]
39. Multicenter analytical performance evaluation of a fully automated anti-Müllerian hormone assay and reference interval determination.
Anckaert E; Öktem M; Thies A; Cohen-Bacrie M; Daan NM; Schiettecatte J; Müller C; Topcu D; Gröning A; Ternaux F; Engel C; Engelmann S; Milczynski C
Clin Biochem; 2016 Feb; 49(3):260-7. PubMed ID: 26500002
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies.
Weber MC; Risch M; Thiel SL; Grossmann K; Nigg S; Wohlwend N; Lung T; Hillmann D; Ritzler M; Ferrara F; Bigler S; Egli K; Bodmer T; Imperiali M; Salimi Y; Fleisch F; Cusini A; Heer S; Renz H; Paprotny M; Kohler P; Vernazza P; Risch L; Kahlert CR
Dis Markers; 2021; 2021():8810196. PubMed ID: 33532006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
